![James Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kelly
Director of Finance/CFO at
NOVAVAX, INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Presently, James Patrick Kelly holds the position of Chief Financial Officer, Treasurer & Executive VP of Novavax, Inc. He is also Member of The Association of Bioscience Financial Officers. In his past career he held the position of Chief Financial Officer, Treasurer & Executive VP for Vanda Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President at Supernus Pharmaceuticals, Inc., Director-Planning & Operations at Biogen, Inc., Principal at Aetna, Inc. and Vice President & Controller for MedImmune LLC. Mr. Kelly received an MBA from Cornell University and an undergraduate degree from the University of Vermont.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC. 0.08% | 2026-04-22 | 130,599 ( 0.08% ) | 1 M $ | 2026-05-30 |
James Kelly active positions
| Companies | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Director of Finance/CFO | 2021-08-15 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Former positions of James Kelly
| Companies | Position | End |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-08-12 |
| VANDA PHARMACEUTICALS INC. | Director of Finance/CFO | 2020-03-14 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 2010-11-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2005-10-31 |
| AETNA | Corporate Officer/Principal | 2000-05-31 |
Training of James Kelly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Provides health insurance plans services | Health Services |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
- Stock Market
- Insiders
- James Kelly
